Researchers assembled a retrospective cohort from electronic health records at Hospices Civils de Lyon covering October 2016 through April 2025. The cohort included adult patients (≥18 years) who were either hospitalized or presented to the emergency department and had an ICD-10 diagnostic code for acute respiratory infections or a laboratory-confirmed viral detection during the study period. Investigators extracted administrative variables and laboratory results recorded during each stay. The dataset consisted of 103,011 hospital visits corresponding to 82,077 unique adult patients. Individual-level data are not publicly available because of legal and ethical restrictions; the source explicitly states this limitation.
The number of eligible stays increased substantially after the COVID-19 pandemic period. Year-round laboratory testing became more common, replacing the strictly seasonal testing patterns seen before the pandemic. Winter peaks in ARI incidence, and in particular detections of influenza and RSV, were disrupted during the pandemic years but re-emerged after 2022. The study team reported this return to seasonal peaks based on routine hospital surveillance data, reflecting changes both in patient presentations and testing practices over the nine-year window.
Positivity rates differed by viral agent and by age strata. The study team observed that influenza, rhinovirus, and SARS-CoV-2 reached their highest positivity rates in younger adults (defined in the article as <65 years). In contrast, RSV and hMPV positivity rates were highest among the oldest patients (≥80 years). The authors reported these patterns descriptively; the source does not supply additional stratified prevalence percentages or exact age distribution tables in the abstract, so readers should consult the full preprint for more granular numbers.
Older adults experienced more severe outcomes overall. Patients aged ≥65 years had longer hospital stays (median 10 days) compared with younger adults (median 8 days); the authors reported p<0.001 for this comparison. In-hospital mortality was approximately twice as high in patients ≥65 years (14%) versus younger adults (7%), again with p<0.001 noted. Interestingly, ICU admission was less frequent in the older group (21% vs 33%, p<0.001), and the use of respiratory support was also reported as lower in the older cohort. The study team therefore documented a pattern where older patients had higher mortality and longer admissions but fewer ICU admissions and lower utilization of respiratory support—details the authors attributed to clinical decision-making, frailty profiles, or underlying treatment pathways; however, the abstract does not enumerate those causal factors.
The authors compared length of stay across viral etiologies. Influenza was associated with the shortest hospital length of stay among the viruses reported. In contrast, human metapneumovirus (hMPV) infections were associated with the longest lengths of stay in younger adults. The source text does not provide exact median lengths for each virus beyond these relative statements in the abstract; the full preprint and supplementary material likely contain the detailed breakdowns.
Ethics approval and oversight were declared: the Ethics committee of Hospices Civils de Lyon and the Commission Nationale de l'Informatique et des Libertés reviewed and approved the work. The authors confirmed that appropriate patient consent or archival procedures were followed as described. Funding was reported from the Agence Nationale de la Recherche (ANR-23-CHIN-0002-01). The manuscript is posted as a medRxiv preprint and has not undergone peer review; the article carries a declaration of competing interests for one author (grants and personal fees from vaccine manufacturers as specified in the source). Due to legal and ethical protections, individual-level data cannot be shared publicly, although the authors list supplementary material and data/code links available through the preprint portal.
Study limitations and unresolved questions
This report is retrospective and based on routine EHR and laboratory data; therefore it reflects testing and admission practices in addition to true community viral circulation. The abstract notes changes in testing patterns over time—particularly increased year-round testing after the COVID-19 pandemic—which can influence observed incidence and positivity trends. The paper is a preprint and has not been peer-reviewed; readers should interpret findings accordingly and consult the full manuscript and supplementary material for granular methods, stratified results, and adjusted analyses. The source did not report detailed per-virus median lengths of stay within the abstract, nor the full set of covariates used for severity analyses; those methodological details were not provided in the abstract and require review of the complete preprint for confirmation.